- Heads M&A strategy, pipeline, and execution including diligence, valuation, and deal closing.
- Owns post-close integration planning and cross-functional leadership to realize deal value.
- Partners on de novo development and strategic partnerships to scale operations.
Groups provides value-based addiction care, expanding its clinical model into new states and markets. As an executive team member, this leader drives M&A and strategic growth in a mission-driven organization.